Prothena reported $-0.97 in EPS Earnings Per Share for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Eps Change
Acadia Pharmaceuticals ACAD:US USD 0 0
Agios Pharmaceuticals AGIO:US USD -1.49 0.19
Akebia Therapeutics AKBA:US USD -0.28 0.51
ALKERMES ALKS:US USD 0.02 0.04
Alnylam Pharmaceuticals ALNY:US USD -2.69 0.4
Amgen AMGN:US USD 4.7 0.05
Biogen BIIB:US USD 4.77 0.48
Biomarin Pharmaceutical BMRN:US USD -0.04 0.19
Bluebird Bio BLUE:US USD -0.94 0.33
Exelixis EXEL:US USD 0.23 0.01
Intercept Pharmaceuticals ICPT:US USD 7.8 8.48
Intra Cellular Therapies ITCI:US USD -0.57 0.35
IONIS PHARMACEUT IONS:US USD -0.33 0.41
Macrogenics MGNX:US USD -0.4 0.27
Nektar Therapeutics NKTR:US USD -0.31 0.54
Neurocrine Biosciences NBIX:US USD 0.69 0.87
Prothena PRTA:US USD -0.97 0.09
Regeneron Pharmaceuticals REGN:US USD 11.14 1.37
Seattle Genetics SGEN:US USD -1.03 0.3
Ultragenyx Pharmaceutical RARE:US USD -3.5 1.24
Vertex Pharmaceuticals VRTX:US USD 4.01 0.41
Vital Therapies VTL:US USD -0.69 0.03
Xoma XOMA:US USD -0.48 0.05
YTE INCY:US USD 0.6 0.41